Dexamethasone-sparing Based on Netupitant/Palonosetron(NEPA) With Olanzapine for the Effect of Chemotherapy-induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: a Randomized Noninferiority III Phase Trial
Latest Information Update: 29 Mar 2024
At a glance
- Drugs Dexamethasone (Primary) ; Netupitant/palonosetron (Primary) ; Olanzapine (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
Most Recent Events
- 29 Mar 2024 New trial record